A Polivka

Phase I trial of recombinant interleukin-2 and cyclophosphamide: augmentation of cellular immunity and T-cell mitogenic response with long-term administration of rIL-2.

Kolitz Je, Wong Gy, Karl Welte et al. · PubMed · 1988 · 35 citations

Medicine, Oncology, Pharmacology +15

Purification to Apparent Homogeneity and Biochemical Characterization of Human Pluripotent Hematopoietic Colony-Stimulating Factor

Karl Welte, E Platzer, Janice Gabrilove et al. · Hämatologie und Bluttransfusion · 1985 · 17 citations

Life Sciences, Biochemistry, Hematology +10

Expansion of activated T-lymphocytes in patients treated with recombinant interleukin 2.

Kolitz Je, Karl Welte, Wong Gy et al. · PubMed · 1987 · 15 citations

Life Sciences, Immunology, Oncology +14

Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.

Tammo Bialas, Jonathan E. Kolitz, Ester Levi et al. · PubMed · 1988 · 13 citations

Life Sciences, Immunology, Cellular Immunology +8